🇺🇸 FDA
Patent

US 11078256

Methods and compositions for inhibiting cancer cell growth

granted A61KA61K38/00A61K9/0019

Quick answer

US patent 11078256 (Methods and compositions for inhibiting cancer cell growth) held by The Board of Regents of the University of Texas System expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K9/0019, A61K9/19, A61P